Sep 9
The future of Alzheimer’s disease: blood biomarkers, brain imaging, and screening the cognitively unimpaired
What will Alzheimer’s disease diagnosis look like in 5–10 years? In this episode of In Conversation With…, Laura Hart is joined by the authors behind The Lancet Neurology Series on Future Directions in Alzheimer’s Disease and Related Disorders: Clifford Jack (Mayo Clinic), Charlo ... Show More
28m 49s
Jul 15
Jan D Lünemann and Christian Münz on Epstein–Barr virus and multiple sclerosis
In this episode, Heather Brown, Senior Editor at The Lancet Neurology, chats with Jan Lünemann (University of British Columbia, Canada) and Christian Münz (University of Zürich, Switzerland) about their Rapid Review on Epstein-Barr virus (EBV) and multiple sclerosis (MS). EBV, a ... Show More
15m 45s
Dec 2022
108| Functional Neurological Disorders – A Conversation With Dr. Mark Hallett
<p>In this episode, we speak with Dr. Mark Hallett about functional neurological disorders (FNDs). We cover the history, epidemiology, symptomatology, and pathophysiology of FNDs. We touch on the issue of "lumping versus splitting," controversies in the literature, the need for b ... Show More
1h 19m
Mark Hallett (National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA) discusses his Review, published in the June issue of The Lancet Neurology, on functional neurological disorder, and talks about new subtypes of this disorder, diagnostic challenges, and how education is important. Read the full article: Functional neurological disorder ... Show More
<p><span data-sheets-value= "{"1":2,"2":"Dr. Jeff Ratlif talks with Dr. Louise Klebanoff about the decline of true general neurologist and it's impact on patients. Read the related article in JAMANeurology. "}" data-sheets-userformat= "{"2":15297,"3":{"1":0},"9":0,"10":1,"11":4," ... Show More
